USPTO serial 79076423
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan Myers
Jonathan Myers and Andrew Wilford K.F. ROSS P.C.5683 RIVERDALE AVENUE BOX 900CUSTOMER NUMBER 535BRONX, NY 10471-0900| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for cell cultures; cell culture media, namely, culture media for endothelial and myocardiac cells; culture media for cell growth for medical biotechnology, namely,culture media for growing and regenerating endothelial and myocardiac cells; biological reagents for molecular biology; chemical reagents for medical use for biological processes; carriers of culture media for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; cellular function activating agents, namely,cell growth factors, hematopoietic factors, serums, namely, human and animal serums for cell culture; antibodies, namely, monoclonal antibodies for detection and treatment of pathologies; all these products being for medical use | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus and instruments, namely, intravascular cell reinjection catheters; apparatus for human cell culture, namely, medical device for providing human cell culture diagnosis and treatment; cell analyzers for medical treatment and diagnostic use; medical device for production of human cell grafts, namely, medical device allowing in vitro stem cell expansion for therapeutic use; instruments for cell culture, namely, medical instruments used for cell culture diagnosis and treatment; medical device for human cell selection, namely, medical device for human cell immune selection used for diagnosis and treatment | SECTION 71 - CANCELLED | — |
| 042 | Research and development of new products in the field of biotechnology; services for scientific analysis for medical purposes, namely, medical research laboratory services; development of new products for medical research for third parties | SECTION 71 - CANCELLED | — |
| 044 | Medical care and treatment; medical services for cell sampling and isolation, namely, leukapheresis medical treatment services; services for medical analysis relating to treating individuals, namely, behavior analysis for medical purposes; therapeutic treatment, namely, cell therapy for regenerative medicine | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 30, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 29, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 4, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 29, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 21, 2020 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Feb 21, 2020 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 22, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 1, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 14, 2018 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 27, 2018 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 27, 2018 | INPC | INVALIDATION PROCESSED | — |
| Sep 26, 2018 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 26, 2018 | C71T | CANCELLED SECTION 71 | — |
| May 14, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 17, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 17, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 21, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 21, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 11, 2011 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 25, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 25, 2011 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 5, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 17, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 17, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 16, 2011 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 2, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 2, 2011 | ALIE | ASSIGNED TO LIE | — |
| Feb 2, 2011 | ALIE | ASSIGNED TO LIE | — |
| Jan 31, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 24, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 24, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 24, 2011 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 11, 2010 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 10, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 10, 2010 | DMCC | DATA MODIFICATION COMPLETED | — |
| Jul 20, 2010 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 20, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2010 | ALIE | ASSIGNED TO LIE | — |
| Jul 6, 2010 | PAPER RECEIVED | — | |
| Jan 29, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 6, 2010 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 6, 2010 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 6, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 5, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 2, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 29, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 29, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |